124 related articles for article (PubMed ID: 25043320)
1. DISC1-TSNAX and DAOA genes in major depression and citalopram efficacy.
Arias B; Fabbri C; Serretti A; Drago A; Mitjans M; Gastó C; Catalán R; Fañanás L
J Affect Disord; 2014 Oct; 168():91-7. PubMed ID: 25043320
[TBL] [Abstract][Full Text] [Related]
2. Translin-associated factor X gene (TSNAX) may be associated with female major depressive disorder in the Japanese population.
Okuda A; Kishi T; Okochi T; Ikeda M; Kitajima T; Tsunoka T; Okumukura T; Fukuo Y; Kinoshita Y; Kawashima K; Yamanouchi Y; Inada T; Ozaki N; Iwata N
Neuromolecular Med; 2010 Mar; 12(1):78-85. PubMed ID: 19760522
[TBL] [Abstract][Full Text] [Related]
3. Association of DISC1 and TSNAX genes and affective disorders in the depression case-control (DeCC) and bipolar affective case-control (BACCS) studies.
Schosser A; Gaysina D; Cohen-Woods S; Chow PC; Martucci L; Craddock N; Farmer A; Korszun A; Gunasinghe C; Gray J; Jones L; Tozzi F; Perry J; Muglia P; Owen MJ; Craig IW; McGuffin P
Mol Psychiatry; 2010 Aug; 15(8):844-9. PubMed ID: 19255581
[TBL] [Abstract][Full Text] [Related]
4. No evidence of DISC1-associated morphological changes in the hippocampus, anterior cingulate cortex, or striatum in major depressive disorder cases and healthy controls.
Stacey D; Redlich R; Opel N; Grotegerd D; Arolt V; Kugel H; Heindel W; Baune BT; Dannlowski U
J Affect Disord; 2014 Sep; 166():103-7. PubMed ID: 25012417
[TBL] [Abstract][Full Text] [Related]
5. Lack of association between translin-associated factor X gene (TSNAX) and methamphetamine dependence in the Japanese population.
Kishi T; Okochi T; Kitajima T; Ujike H; Inada T; Yamada M; Uchimura N; Sora I; Iyo M; Ozaki N; Correll CU; Iwata N
Prog Neuropsychopharmacol Biol Psychiatry; 2011 Aug; 35(7):1618-22. PubMed ID: 21683752
[TBL] [Abstract][Full Text] [Related]
6. DAOA variants on diagnosis and response to treatment in patients with major depressive disorder and bipolar disorder.
Chiesa A; Pae CU; Porcelli S; Han C; Lee SJ; Patkar AA; Park MH; Jun TY; Serretti A
J Int Med Res; 2012; 40(1):258-65. PubMed ID: 22429365
[TBL] [Abstract][Full Text] [Related]
7. Gender-specific association of TSNAX/DISC1 locus for schizophrenia and bipolar affective disorder in South Indian population.
Ram Murthy A; Purushottam M; Kiran Kumar HB; ValliKiran M; Krishna N; Jayramu Sriharsha K; Janardhan Reddy YC; Ghosh S; Jain S
J Hum Genet; 2012 Aug; 57(8):523-30. PubMed ID: 22673686
[TBL] [Abstract][Full Text] [Related]
8. A genomewide association study of citalopram response in major depressive disorder.
Garriock HA; Kraft JB; Shyn SI; Peters EJ; Yokoyama JS; Jenkins GD; Reinalda MS; Slager SL; McGrath PJ; Hamilton SP
Biol Psychiatry; 2010 Jan; 67(2):133-8. PubMed ID: 19846067
[TBL] [Abstract][Full Text] [Related]
9. Association of polymorphisms in genes regulating the corticotropin-releasing factor system with antidepressant treatment response.
Binder EB; Owens MJ; Liu W; Deveau TC; Rush AJ; Trivedi MH; Fava M; Bradley B; Ressler KJ; Nemeroff CB
Arch Gen Psychiatry; 2010 Apr; 67(4):369-79. PubMed ID: 20368512
[TBL] [Abstract][Full Text] [Related]
10. Neuroplasticity and second messenger pathways in antidepressant efficacy: pharmacogenetic results from a prospective trial investigating treatment resistance.
Fabbri C; Crisafulli C; Calati R; Albani D; Forloni G; Calabrò M; Martines R; Kasper S; Zohar J; Juven-Wetzler A; Souery D; Montgomery S; Mendlewicz J; Serretti A
Eur Arch Psychiatry Clin Neurosci; 2017 Dec; 267(8):723-735. PubMed ID: 28260126
[TBL] [Abstract][Full Text] [Related]
11. The interaction of NOS1AP, DISC1, DAOA, and GSK3B confers susceptibility of early-onset schizophrenia in Chinese Han population.
Hu G; Yang C; Zhao L; Fan Y; Lv Q; Zhao J; Zhu M; Guo X; Bao C; Xu A; Jie Y; Jiang Y; Zhang C; Yu S; Wang Z; Li Z; Yi Z
Prog Neuropsychopharmacol Biol Psychiatry; 2018 Feb; 81():187-193. PubMed ID: 29100974
[TBL] [Abstract][Full Text] [Related]
12. The impact of catechol-O-methyltransferase SNPs and haplotypes on treatment response phenotypes in major depressive disorder: a case-control association study.
Kocabas NA; Faghel C; Barreto M; Kasper S; Linotte S; Mendlewicz J; Noro M; Oswald P; Souery D; Zohar J; Massat I
Int Clin Psychopharmacol; 2010 Jul; 25(4):218-27. PubMed ID: 20531207
[TBL] [Abstract][Full Text] [Related]
13. Genotypic association of the DAOA gene with resting-state brain activity in major depression.
Chen J; Xu Y; Zhang J; Liu Z; Xu C; Zhang K; Shen Y; Xu Q
Mol Neurobiol; 2012 Oct; 46(2):361-73. PubMed ID: 22851402
[TBL] [Abstract][Full Text] [Related]
14. Genetic variability at HPA axis in major depression and clinical response to antidepressant treatment.
Papiol S; Arias B; Gastó C; Gutiérrez B; Catalán R; Fañanás L
J Affect Disord; 2007 Dec; 104(1-3):83-90. PubMed ID: 17467808
[TBL] [Abstract][Full Text] [Related]
15. Association of distinct allelic haplotypes of DISC1 with psychotic and bipolar spectrum disorders and with underlying cognitive impairments.
Palo OM; Antila M; Silander K; Hennah W; Kilpinen H; Soronen P; Tuulio-Henriksson A; Kieseppä T; Partonen T; Lönnqvist J; Peltonen L; Paunio T
Hum Mol Genet; 2007 Oct; 16(20):2517-28. PubMed ID: 17673452
[TBL] [Abstract][Full Text] [Related]
16. Genetic association analysis of functional polymorphisms in neuronal nitric oxide synthase 1 gene (NOS1) and mood disorders and fluvoxamine response in major depressive disorder in the Japanese population.
Okumura T; Kishi T; Okochi T; Ikeda M; Kitajima T; Yamanouchi Y; Kinoshita Y; Kawashima K; Tsunoka T; Inada T; Ozaki N; Iwata N
Neuropsychobiology; 2010; 61(2):57-63. PubMed ID: 20016223
[TBL] [Abstract][Full Text] [Related]
17. Common genetic variation and antidepressant efficacy in major depressive disorder: a meta-analysis of three genome-wide pharmacogenetic studies.
; ;
Am J Psychiatry; 2013 Feb; 170(2):207-17. PubMed ID: 23377640
[TBL] [Abstract][Full Text] [Related]
18. Genome-wide pharmacogenomic study of citalopram-induced side effects in STAR*D.
Adkins DE; Clark SL; Åberg K; Hettema JM; Bukszár J; McClay JL; Souza RP; van den Oord EJ
Transl Psychiatry; 2012 Jul; 2(7):e129. PubMed ID: 22760553
[TBL] [Abstract][Full Text] [Related]
19. A molecular pathway analysis of the glutamatergic-monoaminergic interplay serves to investigate the number of depressive records during citalopram treatment.
Drago A; Cocchi E; Crisafulli C; Serretti A
J Neural Transm (Vienna); 2015 Mar; 122(3):465-75. PubMed ID: 24986638
[TBL] [Abstract][Full Text] [Related]
20. Association of mu-opioid receptor variants and response to citalopram treatment in major depressive disorder.
Garriock HA; Tanowitz M; Kraft JB; Dang VC; Peters EJ; Jenkins GD; Reinalda MS; McGrath PJ; von Zastrow M; Slager SL; Hamilton SP
Am J Psychiatry; 2010 May; 167(5):565-73. PubMed ID: 20194481
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
